衰弱是接受血管内治疗的急性缺血性卒中患者结局的预测因素
本研究为回顾性研究,纳入2012至2017年间接受血管内治疗的489例前循环急性缺血性卒中患者,计算出院时医院衰弱风险评分(HFRS)。约29.7%患者存在高衰弱风险(HFRS>15分),高衰弱风险与3个月良好结局可能性降低独立相关(校正OR=0.48,95%CI 0.26-0.89)。
要点
- 高衰弱风险(HFRS>15分)与血管内治疗后3个月良好结局可能性降低独立相关。
- HFRS对3个月结局的诊断性能与THRIVE、PRE、SPAN-100评分相似。
- 衰弱可作为急性缺血性卒中血管内治疗患者的结局预测因素。
核心结论
- 衰弱是接受血管内治疗的急性缺血性卒中患者结局的独立预测因素。
研究设计与样本
- 回顾性研究,基于前瞻性收集的连续患者登记,纳入2012至2017年间接受血管内治疗的前循环急性缺血性卒中患者489例。
- 计算每位患者出院时的医院衰弱风险评分(HFRS),比较3个月良好结局(改良Rankin量表0-2分)与不良结局(3-6分)两组。
- 采用多变量逻辑回归模型识别与3个月良好结局独立相关的变量,并使用诊断检验统计比较HFRS与其他卒中预后评分。
主要发现
- 患者中位年龄75.6岁(IQR 65.3-82.3),中位NIHSS 15分(IQR 11-19)。
- 约29.7%患者呈现高衰弱风险(HFRS>15分)。
- 3个月良好结局患者HFRS较低且高衰弱风险患病率较低。
- 高衰弱风险与3个月良好结局可能性降低独立相关(校正OR=0.48,95%CI 0.26-0.89)。
- HFRS与其他预后评分(THRIVE、PRE评分、SPAN-100指数)对3个月结局的诊断性能相似。
临床怎么用
- 对于接受血管内治疗的急性缺血性卒中患者,可使用HFRS评估衰弱风险以辅助预测3个月功能结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Frailty is a disorder of multiple physiological systems impairing the capacity of the organism to cope with insult or stress. It is associated with poor outcomes after acute illness. Our aim was to study the impact of frailty on the functional outcome of patients with acute ischemic stroke (AIS) submitted to endovascular stroke treatment (EST). METHODS: We performed a retrospective study of patients with AIS of the anterior circulation submitted to EST between 2012 and 2017, based on a prospectively collected local registry of consecutive patients. The Hospital Frailty Risk Score (HFRS) at discharge was calculated for each patient. We compared groups of patients with and without favourable 3-month outcome after index AIS (modified Rankin Scale 0-2 and 3-6, respectively). A multivariable logistic regression model was used to identify variables independently associated with favourable 3-month outcome. Diagnostic test statistics were used to compare HFRS with other prognostic scores for AIS. RESULTS: We included 489 patients with median age 75.6 years (interquartile range [IQR] = 65.3-82.3) and median NIHSS 15 (IQR = 11-19). About 29.7% presented a high frailty risk (HFRS >15 points). Patients with favourable 3-month outcome presented lower HFRS and lower prevalence of high frailty risk. High frailty risk was independently associated with decreased likelihood of favourable 3-month outcome (adjusted odds ratio = 0.48, 95% confidence interval = 0.26-0.89). Diagnostic performances of HFRS and other prognostic scores (THRIVE and PRE scores, SPAN-100 index) for outcome at 3-months were similar. DISCUSSION: Frailty is an independent predictor of outcome in AIS patients submitted to EST.
引用
- Pinho J, Küppers C, Nikoubashman O, et al. Frailty is an outcome predictor in patients with acute ischemic stroke receiving endovascular treatment. Age Ageing. 2021. PMID: 34087930. doi:10.1093/ageing/afab092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。